The UAB Research Foundation;Incysus Therapeutics, Inc.
发明人:
Steven A. Lisi,William Ho,Lawrence S. Lamb, JR.
申请号:
US16278336
公开号:
US20190381100A1
申请日:
2019.02.18
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present invention provides compositions and methods for combination therapy comprising administering to a patient in need thereof, drug-resistant immunotherapy, immune checkpoint inhibitors, and chemotherapy for the treatment of cancer.